| Literature DB >> 35154334 |
Zhaowei Kong1, On Kei Lei1, Shengyan Sun2, Lei Li3, Qingde Shi4, Haifeng Zhang5, Jinlei Nie4.
Abstract
OBJECTIVE: The purpose of this study was to investigate the effects of repeated sprint interval training (RSIT) under different hypoxic conditions in comparison with normoxic RSIT on cardiorespiratory fitness (CRF) and metabolic health in sedentary young women.Entities:
Keywords: Aerobic capacity; High-intensity interval training; Hypoxia; Metabolic health
Year: 2022 PMID: 35154334 PMCID: PMC8819388 DOI: 10.1016/j.jesf.2022.01.005
Source DB: PubMed Journal: J Exerc Sci Fit ISSN: 1728-869X Impact factor: 3.103
Training parameters during the intervention.
| N | H2500 | H2500-3400 | Time effect | Group effect | Time × group effect | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Workload (kg) | ||||||||||||
| wk1 | 1.1 | ±0.1 | 1.1 | ±0.1 | 1.0 | ±0.1 | <0.001 | 0.707 | 0.223 | 0.071 | 0.097 | 0.100 |
| wk2 | 1.6 | ±0.3a | 1.5 | ±0.3a | 1.5 | ±0.3a | ||||||
| wk3 | 2.0 | ±0.6 ab | 2.0 | ±0.6 ab | 1.8 | ±0.6 ab | ||||||
| wk4 | 2.3 | ±0.8 abc | 2.5 | ±0.8 abc | 1.9 | ±0.7 ab | ||||||
| Duration (min) | ||||||||||||
| wk1 | 16.7 | ±4.2 | 16.2 | ±4.7 | 14.9 | ±6.7 | 0.002 | 0.133 | 0.123 | 0.097 | 0.479 | 0.043 |
| wk2 | 17.3 | ±3.9 | 17.7 | ±2.9 | 15.1 | ±4.6 | ||||||
| wk3 | 14.8 | ±4.2 ab | 16.8 | ±4.3 | 12.1 | ±5.0b | ||||||
| wk4 | 12.9 | ±5.0 ab | 14.8 | ±5.0b | 12.9 | ±4.9 | ||||||
| MPO (W•kg−1) | ||||||||||||
| wk1 | 1.9 | ±0.2 | 1.9 | ±0.2 | 2.0 | ±0.4 | <0.001 | 0.367 | 0.866 | 0.007 | 0.760 | 0.017 |
| wk2 | 2.3 | ±0.4 ab | 2.4 | ±0.4 ab | 2.2 | ±0.6 | ||||||
| wk3 | 2.5 | ±0.7 ab | 2.6 | ±0.7 ab | 2.6 | ±0.9 ab | ||||||
| wk4 | 2.6 | ±1.0 ab | 2.8 | ±0.8 ab | 2.6 | ±1.0 ab | ||||||
| % HRmax | ||||||||||||
| wk1 | 91.2 | ±3.6 | 90.7 | ±5.6 | 93.2 | ±4.1 | <0.001 | 0.202 | 0.949 | 0.003 | 0.142 | 0.077 |
| wk2 | 89.0 | ±3.7a | 90.4 | ±3.9 | 89.4 | ±4.4a | ||||||
| wk3 | 89.3 | ±4.5a | 88.5 | ±5.5 | 89.4 | ±3.9a | ||||||
| wk4 | 89.4 | ±3.9 | 88.1 | ±4.9 ab | 87.7 | ±7.5a | ||||||
| TRIMP (au) | ||||||||||||
| wk1 | 57.3 | ±16.6 | 53.6 | ±16.7 | 59.5 | ±18.7 | <0.001 | 0.232 | 0.876 | 0.007 | 0.295 | 0.062 |
| wk2 | 54.0 | ±9.6 | 56.2 | ±9.8 | 50.0 | ±16.1 | ||||||
| wk3 | 49.3 | ±12.1a | 48.9 | ±13.5 | 40.9 | ±16.5a | ||||||
| wk4 | 40.8 | ±12.3 ab | 43.7 | ±11.7b | 44.4 | ±18.3a | ||||||
Values are expressed as means ± standard deviation. MPO: mean power output relative to body weight, %HRmax: percentage of maximal heart rate, TRIMP (au): training impulse (arbitrary unit), N: repeated sprint interval training in normoxia, H2500: repeated sprint interval training in normobaric hypoxia simulated at 2500 m, H2500-3400: repeated sprint interval training in normobaric hypoxia simulated at 2500–3400 m.
Significantly different from the corresponding a wk1, b wk2 and c wk3 values in the same group (p < 0.05).
Fig. 1Blood oxygen saturation (SpO2) during the intervention Significantly different from N (H2500/H2500–3400 vs. N) at ∗p < 0.01.
Habitual energy intake and physical activity before, during and after intervention.
| C | N | H2500 | H2500-3400 | Time effect | Group effect | Time × group effect | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Energy intake (kcal•day−1) | ||||||||||||||
| Pre | 2118 | ±499 | 1837 | ±630 | 1928 | ±575 | 1661 | ±292 | 0.439 | 0.025 | 0.178 | 0.120 | 0.580 | 0.065 |
| wk1 | 2164 | ±423 | 1497 | ±404 | 1719 | ±599 | 1764 | ±460 | ||||||
| wk2 | 2055 | ±516 | 1684 | ±403 | 1964 | ±609 | 1817 | ±517 | ||||||
| wk3 | 1877 | ±347 | 1837 | ±721 | 1810 | ±680 | 1698 | ±355 | ||||||
| wk4 | 2029 | ±771 | 1687 | ±209 | 1918 | ±750 | 1776 | ±490 | ||||||
| Post | 2063 | ±518 | 1479 | ±599 | 1602 | ±631 | 1760 | ±559 | ||||||
| Physical activity (steps•day-1) | ||||||||||||||
| Pre | 7579 | ±4451 | 8770 | ±2628 | 8675 | ±2262 | 7779 | ±2750 | 0.577 | 0.019 | 0.845 | 0.020 | 0.305 | 0.082 |
| wk1 | 9285 | ±3906 | 8813 | ±2663 | 8842 | ±2879 | 8230 | ±2262 | ||||||
| wk2 | 7882 | ±3070 | 9031 | ±3744 | 8011 | ±3317 | 7024 | ±1968 | ||||||
| wk3 | 8580 | ±2790 | 8802 | ±3753 | 7697 | ±1857 | 8685 | ±2806 | ||||||
| wk4 | 7707 | ±3394 | 8802 | ±3753 | 7764 | ±2793 | 8612 | ±2363 | ||||||
| Post | 6168 | ±3266 | 8177 | ±2642 | 8113 | ±2344 | 9530 | ±3771 | ||||||
Values are expressed as means ± standard deviation. C: control group, N: normoxic repeated sprint interval training, H2500: hypoxic repeated sprint interval training at 2500 m, H2500–3400: hypoxic repeated sprint interval training at 2500–3400 m.
Changes in blood outcome measures before and after the intervention.
| C | N | H2500 | H2500-3400 | Group effect | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | Pre | Post | |||||||||||
| Age (y) | 22.2 | ±3.8 | 20.9 | ±2.6 | 21.9 | ±2.0 | 21.9 | ±2.2 | ||||||||||
| Height (cm) | 162.6 | ±5.5 | 161.7 | ±4.6 | 162.4 | ±5.9 | 160.9 | ±4.8 | ||||||||||
| Weight (kg) | 61.0 | ±7.1 | 60.8 | ±6.7 | 59.1 | ±8.3 | 59.4 | ±8.0 | 57.3 | ±7.5 | 57.2 | ±7.3 | 58.8 | ±11.5 | 59.0 | ±11.7 | 0.602 | 0.033 |
| BMI (kg•m−2) | 23.0 | ±2.3 | 23.0 | ±2.1 | 22.6 | ±3.1 | 22.7 | ±3.0 | 21.7 | ±2.4 | 21.7 | ±2.4 | 22.7 | ±4.2 | 22.8 | ±4.3 | 0.569 | 0.036 |
| Glucose (mmol•L−1) | 4.6 | ±0.4 | 4.5 | ±0.4 | 4.6 | ±0.2 | 4.6 | ±0.3 | 4.6 | ±0.3 | 4.6 | ±0.3 | 4.5 | ±0.3 | 4.7 | ±0.3 | 0.582 | 0.039 |
| TC (mmol•L−1) | 4.9 | ±1.0 | 5.0 | ±1.0 | 4.9 | ±1.0 | 4.4 | ±0.7 | 4.8 | ±0.9 | 4.6 | ±1.1 | 4.6 | ±0.7 | 4.8 | ±0.9 | 0.099 | 0.119 |
| LDL-C (mmol•L−1) | 2.9 | ±0.9 | 3.0 | ±0.9 | 2.9 | ±0.9 | 2.6 | ±0.6 | 2.9 | ±0.9 | 2.7 | ±0.9 | 2.9 | ±0.5 | 2.8 | ±0.9 | 0.486 | 0.048 |
| HDL-C (mmol•L−1) | 1.8 | ±0.3 | 1.8 | ±0.3 | 1.7 | ±0.4 | 1.6 | ±0.5 | 1.7 | ±0.6 | 1.8 | ±0.9 | 1.5 | ±0.3 | 1.7 | ±0.4 | 0.269 | 0.076 |
| Triglyceride (mmol•L−1) | 0.9 | ±0.3 | 0.8 | ±0.4 | 1.0 | ±0.4 | 1.0 | ±0.3 | 0.9 | ±0.3 | 0.9 | ±0.3 | 1.0 | ±0.4 | 1.2 | ±0.4 | 0.071 | 0.132 |
Observed values are expressed as means ± standard deviation. C: control group, N: normoxic repeated sprint interval training, H2500: hypoxic repeated sprint interval training at 2500 m, H2500–3400: hypoxic repeated sprint interval training at 2500–3400 m, BMI: body mass index, TC: total cholesterol, LDL-C: low-density lipoprotein cholesterol, HDL-C: high-density lipoprotein cholesterol.
Changes in maximal gas exchange data and related parameters before and after the intervention.
| C | N | H2500 | H2500-3400 | Group effect | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre | Post | Δ% | Pre | Post | Δ% | Pre | Post | Δ% | Pre | Post | Δ% | |||||||||||||||
| V̇O2peak (L•min−1) | 1.6 | ±0.3 | 1.6 | ±0.2 | −1.0 | 0.06 | 1.5 | ±0.3 | 1.6 | ±0.2 | +3.6 | 0.21 | 1.6 | ±0.2 | 1.7 | ±0.3b✝ | +8.3 | 0.52 | 1.5 | ±0.2 | 1.7 | ±0.2b ✝ | +11.9 | 0.99 | 0.027 | 0.153 |
| V̇O2peak (ml•min−1•kg−1) | 25.8 | ±3.9 | 25.8 | ±4.5 | −0.1 | 0.01 | 25.5 | ±3.6 | 26.4 | ±3.2 | +3.6 | 0.27 | 27.8 | ±3.5 | 30.0 | ±3.2b✝‡ | +8.2 | 0.68 | 26.4 | ±5.0 | 29.3 | ±4.0a✝‡ | +10.9 | 0.63 | 0.009 | 0.189 |
| V̇CO2peak (L•min−1) | 1.7 | ±0.3 | 1.7 | ±0.3 | −5.3 | 0.28 | 1.9 | ±0.3 | 2.0 | ±0.3✝ | +4.7 | 0.29 | 2.1 | ±0.2 | 2.3 | ±0.3✝ | +6.5 | 0.53 | 2.0 | ±0.2 | 2.3 | ±0.2b✝ | +12.4 | 1.20 | <0.001 | 0.447 |
| RERpeak | 1.1 | ±0.2 | 1.3 | ±0.1 | −6.5 | 0.42 | 1.3 | ±0.2 | 1.3 | ±0.1✝ | +3.8 | 0.29 | 1.2 | ±0.1 | 1.3 | ±0.1a✝ | +6.5 | 0.61 | 1.2 | ±0.1 | 1.3 | ±0.1b✝ | +11.7 | 1.06 | <0.001 | 0.280 |
| HRpeak (bpm) | 176 | ±11 | 180 | ±9 | +2.2 | 0.40 | 176 | ±12 | 170 | ±13a✝ | −3.7 | 0.50 | 181 | ±10 | 173 | ±9a✝ | −4.4 | 0.82 | 173 | ±12 | 173 | ±9 | −0.4 | 0.07 | 0.020 | 0.162 |
| RPEpeak | 18 | ±2 | 18 | ±2 | +0.7 | 0.07 | 19 | ±2 | 19 | ±2 | +1.1 | 0.12 | 19 | ±1 | 19 | ±2a✝ | −3.1 | 0.45 | 19 | ±1 | 19 | ±1 | +0.4 | 0.07 | 0.572 | 0.035 |
| V̇Epeak (ml•min−1) | 71 | ±14 | 64 | ±11 | −9.8 | 0.55 | 61 | ±10 | 64 | ±12 | +3.8 | 0.20 | 66 | ±10 | 67 | ±10 | +2.7 | 0.18 | 62 | ±11 | 71 | ±13a | +13.4 | 0.70 | 0.101 | 0.106 |
| V̇Epeak/V̇O2peak | 45 | ±9 | 41 | ±4 | −10.7 | 0.69 | 39 | ±5 | 39 | ±6 | −0.6 | 0.05 | 40 | ±6 | 38 | ±6 | −4.7 | 0.34 | 39 | ±7 | 40 | ±8 | +2.9 | 0.16 | 0.693 | 0.026 |
| V̇Epeak/V̇CO2peak | 41 | ±5 | 39 | ±5 | −4.1 | 0.36 | 32 | ±3 | 31 | ±3 | −0.9 | 0.09 | 31 | ±3 | 30 | ±4 | −3.2 | 0.30 | 31 | ±4 | 31 | ±4 | +0.8 | 0.06 | 0.066 | 0.122 |
| O2Ppeak (ml•beat−1) | 8.9 | ±1.5 | 8.6 | ±1.2 | −3.4 | 0.22 | 8.7 | ±1.3 | 9.2 | ±1.2 | +5.6 | 0.39 | 8.8 | ±1.2 | 9.9 | ±1.6b✝ | +13.4 | 0.83 | 8.8 | ±1.0 | 9.9 | ±1.5b✝ | +12.9 | 0.89 | <0.001 | 0.257 |
Observed values are expressed as means ± standard deviation. C: control group, N: normoxic repeated sprint interval training, H2500: hypoxic repeated sprint interval training at 2500 m, H2500–3400: hypoxic repeated sprint interval training at 2500–3400 m, Δ%: change rate from pre to post-intervention, V̇O2peak: peak oxygen uptake, V̇CO2peak: peak carbon dioxide production, RERpeak: peak respiratory exchange ratio, HRpeak: peak heart rate, V̇Epeak: peak minute ventilation, RPEpeak: peak ratings of perceived exertion, O2Ppeak: peak oxygen pulse.Significantly different from pre-training at at ap < 0.05, bp < 0.01. Significantly different from C at ✝ p < 0.05. Significantly different from N at ‡p < 0.05.